baber/WOPTO huggingface dataset:
Patent BR-PI1000834-B1 (BR)
Title: Sistema de cabeça de poço
Inventor: DANIEL W FISH
IPC: E21B33/04
Filed: 2010-03-26
Abstract: sistema de cabeça do poço. trata-se de um sistema de furo do poço (20) que compreende uma montagem de alojamento (22) e uma montagem do dispositivo de suspensão (24). a montagem do dispositivo de suspensão (24) compreende um elemento de atuação (36) que interage com uma parte (38) da montagem do alojamento (22) quando a montagem do dispositivo de suspensão (24) fica posicionada em um local desejado na montagem de alojamento (22). a montagem do dispositivo de suspensão (24) também compreende um elemento de carga (28) que é adaptado para se estender entre a montagem do dispositivo de suspensão (24) e a montagem de alojamento (22) para habilitar que a montagem de alojamento (22) suporte a montagem do dispositivo de suspensão (24). o elemento de carga (28) é conduzido para o interior do furo do poço em uma posição retraida. quando o elemento de atuação (36) interagir com a montagem do alojamento (22) no local desejado, o elemento de atuação (36) atua o elemento de carga (28) para se expandir para fora, para se estender entre a montagem do dispositivo de suspensão (24) e a montagem do alojamento (22). o elemento de atuação (36) é adaptado para transferir uma força de elevação da superfície para o elemento de carga (28), para habilitar que um teste de sobretração da montagem do dispositivo de suspensão (24) seja executado.
Patent BR-PI1006545-B1 (BR)
Title: caixa com partes laterais dobráveis e mecanismos de travamento com proteção de sobrecarga
Inventor: WOLFGANG ORGELDINGER
IPC: B65D6/16
Filed: 2010-04-14
Abstract: caixa com partes laterais dobráveis e mecanismos de travamento com proteção de sobrecarga caixa dobrável (1) caracterizada por compreender um fundo (2) e duas partes externas do lado longitudinal (6a, 6b) e do lado transverso (4a, 4b), cada uma colocada em oposição, em pares, e dobráveis em relação ao fundo (2). cada parte externa do lado longitudinal (6a, 6b) compreende uma saliência (22) f no mínimo, na extremidade do lado transverso que se estende em direção às partes externas do lado transverso (4af 4b), no estado dobrado para cima, que limita a capacidade de dobra das partes externas do lado transverso (4a, 4b) para fora. cada parte externa do lado transverso (4af 4b) inclui um mecanismo de travamento com mola pré-tensionada montado no lado de fora da parte externa do lado transverso (4a, 4b), que no estado dobrado para cima compreende um elemento de fecho (100) passível de movimentação na direção vertical ( 8) f em relação à superfície do fundo, que pode ser fechado com a saliência (22) das partes externas do lado longitudinal (6af 6b).
Patent BR-PI1006732-B1 (BR)
Title: Lente dimensionada para uso num olho humano
Inventor: JOSEF F BILLE
IPC: A61F2/16
Filed: 2010-03-04
Abstract: lente dimensionada para uso num olho humano uma lente para colocação num olho humano, tal como uma lente intraocular, apresenta pelo menos algumas de suas propriedades ópticas formadas com um laser. o laser forma loci modificados na lente quando os loci modificados apresentam um índice de refração diferente do índice de refração do material antes da modificação. diferentes padrões de loci modificados podem prover seleções específicas de potência dióptrica, ajuste tórico, e/ou ajuste asférico. preferencialmente tanto a superfície anterior quanto a superfície posterior da lente são planas a fim de assegurar facilidade para colocação no olho humano.
Patent BR-PI1007230-B1 (BR)
Title: polipeptídeo apresentando a antigenicidade de stx2, seus usos, composição compreendendo o mesmo e célula hospedeira
Inventor: ALISON O'BRIEN
IPC: C07K14/00
Filed: 2010-01-21
Abstract: polipeptídeo apresentando a antigenicidade de stx2, seus usos, composição compreendendo o mesmo e célula hospedeira a invenção refere-se à descoberta do epítopo na proteína de stx2 para o anticorpo 11e10. a invenção apresenta composições contendo polipeptídeos não completos de stx2 que incluem o epítopo do anticorpo monoclonal 11e10. a invenção também apresenta métodos para produção de anticorpos anti-stx2 específicos para o epítopo 11e10 da proteína stx2. adicionalmente, a invenção apresenta métodos para o tratamento de um indivíduo com, ou em risco de desenvolver, a doença associada à toxina de shiga (por exemplo, síndrome hemolítico-urêmica e doenças associadas à infecção por e. coli e s. dysenteriae) com um polipeptídeo que inclui o epítopo 11e10 ou com um anticorpo anti-stx2 desenvolvido usando os métodos da invenção. além disso, a invenção apresenta a detecção de stx2 em uma amostra usando os anticorpos desenvolvidos usando os métodos da invenção.
Patent BR-PI1104632-B1 (BR)
Title: âncora de sutura
Inventor: ANDRÉ FRANCISCO-GUILHERME
IPC: A61B17/04
Filed: 2011-08-29
Abstract: ÂNCORA DE SUTURA SEM NÓ. A presente invenção refere-se a uma âncora de sutura que compreende um corpo tubular que tem um orifício axial através do mesmo e um ou mais meios aprimorados de fixação em uma superfície externa do corpo adaptada para acentuar a fixação do corpo na perfuração do osso, como roscas. Uma porta lateral passa através do corpo a partir do orifício até a superfície externa e é formada de uma ranhura que entra no corpo a partir de sua extremidade proximal. Um comprimento de sutura para fixação de tecido mole ao osso passa ao longo da superfície externa sobre o um ou mais meios aprimorados de fixação, sobre uma extremidade distai do corpo, através do orifício e então novamente para fora do orifício e ao longo da superfície externa sobre o um ou mais meios aprimorados de fixação.
Patent EA-002177-B1 (EA)
Title: Composition for suppressing withdrawal symptoms and craing for alcohol in alcohplics and preventing the abuse of alcohol in healthy subjects
Inventor: FASSI ALDO
IPC: A23L33/00
Filed: 1998-09-18
Abstract: 1. An orally or parenterally administrable composition comprising in admixture L-carnitine, acetyl L-carnitine and propionyl-L-carnitine or the pharmacologically acceptable salt thereof. 2. The composition of Claim 1 as a medicine for suppressing withdrawal symptoms and the craving for alcohol in alcoholics. 3. The composition of Claim 1 as dietary supplement or food products for preventing the abuse of alcohol in substantially healthy subjects. 4. The composition of Claim 1, 2 or 3 wherein the molar ratio L-carnitine:acetyl-L-carnitine:propionyl-L-carnitine or the pharmacologically acceptable salts thereof ranges from 6:4:1 to 3:2:1. 5. The composition of Claim 4 wherein said ratio is 5:4:1. 6. The composition of Claim 4 or 5 in unit dosage form comprising from 0.44 to 0.66 g L-carnitine inner salt; 0.44 to 0.66 g of acetyl L-carnitine inner salt; and from 0.12 to 0.18 g of propionyl-L-carnitine inner salt or equimolar amounts of the pharmacologically acceptable salts thereof. 7. The composition of any of preceding Claims wherein the pharmacologically acceptable salt of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine is selected from group comprising: chloride; bromide; iodide; aspartate, particularly acid aspartate; citrate, particularly acid citrate; tartrate; phosphate, particularly acid phosphate, fumarate particularly acid fumarate; glycerophosphate; glucose phosphate, lactate; maleate, particularly acid maleate; orotate; oxalate, particularly acid oxalate; sulphate, particularly acid sulphate; trichloroacetate, trifluoroacetate and methanesulphonate. 8. The composition of any of preceding Claims further including food supplements, vitamins, co-enzymes and mineral substances. 9. The use of composition of Claim 1 for producing a medicine suppressing withdrawal symptoms and the craving for alcohol in alcoholics. 10. The use of composition of Claim 1 for producing a food products for preventing the abuse of alcohol in substantially healthy individuals. 11. The method of Claim 9 or 10 wherein the molar ratio L-carnitine:acetyl-L-carnitine:propionyl-L-carnitine or the pharmacologically acceptable salts thereof ranges from 6:4:1 to 3:2:1. 12. The method of Claim 11, wherein the molar ratio is 5:4:1.
Patent EA-007378-B1 (EA)
Title: Luminaire having optical transformer providing precalculated angular intensity distribution
Inventor: RIZKIN ALEXANDER
IPC: F21K99/00
Filed: 2001-05-07
Abstract: The luminaire includes a light source (310) that emits light. The emitted light is redirected by a light transformer having a curved circular reflective interior surface (130), the reflective interior surface reflecting the light in a predetermined pattern. A substantial amount of light being may be reflected close to an axis coincident with a radial line defining a radius of the circular reflective interior surface. Additionally, a substantial amount of light may be reflected in a pattern with low divergency or parallel with an axis of the light transformer. The light is transmitted to the exterior of the luminaire by an optical window (110).
Patent EA-007611-B1 (EA)
Title: Cystine-knot fold protein
Inventor: DAVIES MARK DOUGLAS
IPC: A61P29/00
Filed: 2002-12-20
Abstract: This invention relates to a novel protein (INSP002), herein identified as a secreted protein that is a member of the Dan family of the cystine-knot fold cytokine superfamily and to the use of this protein and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
Patent EA-006984-B1 (EA)
Title: Multifunction power convertor
Inventor: WU JIALIN
IPC: H02M7/501
Filed: 2003-04-08
Abstract: The present invention relates to a multifunction power convertor. The multifunction power convertor of the invention is consisted of a rectification circuit, a filter circuit connecting with the rectification circuit, a inverter circuit connecting with the filter circuit, a differential mode voltage suppression reactors (LS, LS, LS) and a filter capacitor group which series connect to the output lines (U, V, W) of the inverter circuit respectively. The character of the present invention lies in that a closed toroidal magnetic core is provided on the output lines (U, V, W) between the differential mode voltage suppression reactor and the filter capacitor group, and the output lines (U, V, W) parallel wind on the closed toroidal magnetic core. The advantages of this invention is that, the high frequency signal is insulated by the closed toroidal magnetic core, and the output of the common mode voltage is depressed, so the waveform of outputting voltage is improved, at the same time, the structure of which is very sample, the cost is reduced greatly, the volume and weight of which is also reduced greatly.
Patent EA-011407-B1 (EA)
Title: Hydrates and polymorphs of 4-[[(7r)-8cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and use thereof as medicaments
Inventor: LINZ GUENTER
IPC: A61K31/519
Filed: 2005-08-11
Abstract: The invention relates to novel hydrates and novel polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and the use thereof as medicaments.
Patent EA-010739-B1 (EA)
Title: Medicament normalizing drain functions and method for preparing thereof
Inventor: KHAVINSON VLADIMIR KHATSKELEVICH
IPC: A61K35/30
Filed: 2007-04-11
Abstract: A number of inventions relates to a medicament and method for preparing thereof using animals' organs, in particular, to a medicament normalizing brain functions, which is a medical preparation for parenteral administration as solution of a peptide complex, a low-molecular fraction content being from 70 to 90% with a molecular mass comprising the peptide components within 72 to 250 Da, peptide concentration being 2.5÷2.9 mg/ml and to a method for preparing thereof from calf brain aged less than 12 month or pigs by extracting acetic acid in the presence of zinc chloride; providing repeated deposition of formed homogenized deposition by twofold volumes of acetone at least two times and subsequent washing through a nutsch filter by twofold volumes of acetone; obtaining an aqueous solution of extract, polypeptide concentrate being 2.5÷2.9 mg/ml; centrifuging, filtering thereof with subsequent ultra-filtration purification at the apparatus with counter pressure not exceeding 1.0 kgs/cmusing materials with retention 15000 Da and adding glycocol in the ultrafiltrate to the final concentration 10÷20 mg/ml at pH=5.6÷6.6 mg/ml and subsequent sterile filtration, ampoulation and autoclaving for 8 minutes at 120°C and atmospheric pressure 1.1 kgs/cm, which provides stability of the medicament and preserving therapeutic effectiveness thereof.
Patent EA-015135-B1 (EA)
Title: Composite seal
Inventor: CAROLAN MICHAEL FRANCIS
IPC: C04B37/02
Filed: 2008-04-16
Abstract: A composite seal is disclosed having first and second metal layers overlying one another in spaced relation. A mineral layer is positioned between the metal layers. The metal and mineral layers have inner and outer perimeters, the inner perimeters overlapping to define an aperture. The metal layers are preferably precious metal or high temperature alloy foil and the mineral layer may be formed of mica, vermiculite, or modifications of vermiculite.
Patent EA-013459-B1 (EA)
Title: Device for filling cigarette tubes with tobacco
Inventor: ANDERSEN JULIA C
IPC: A24C5/42
Filed: 2007-01-19
Abstract: The invention relates to a device (100, 200, 300, 400, 500, 600, 700, 800) for filling cigarette tubes (11) with tobacco, wherein the device (100, 200, 300, 400, 500, 600, 700, 800) comprises at least one suitable separating means (130, 230, 530, 830) by means of which the tobacco can be detached from a tobacco block (1), and also at least one suitable filling means (160, 161, 162, 860) with which the cigarette tube (11) can be filled with the tobacco, wherein the device (100, 200, 300, 400, 500, 600, 700, 800) comprises at least one suitable portioning means (190, 290, 390, 391, 490, 491, 590, 690, 691, 692, 790, 791, 891, 892, 893) for the portioning of a tobacco block (1) and at least one suitable transport means (140, 141, 142, 240, 242, 243, 244, 340, 342, 444, 445, 446, 540, 541, 542, 543, 640, 641, 740, 742, 742a, 743, 840, 842, 845, 846, 847); by means of which the tobacco block (1) can be transported.
Patent EA-012775-B1 (EA)
Title: Blister top foil for blister packs
Inventor: PIESSLINGER JOHANNES
IPC: B65D75/36
Filed: 2007-06-04
Abstract: The invention relates to a blister top foil for sealing with respect to an existing blister bottom foil, wherein the blister top foil comprises at least the following layers, seen from the outside to the inside of the finished pack: possibly a layer of printing undercoat lacquer (c), a layer of printing primer (d), a layer of adhesive (e), a layer of plastic film (f), a layer of possibly peelable adhesive (g), a layer of aluminium (h) and a layer of heat sealing lacquer (i). The invention is characterized in that the printing primer layer (d) is an aluminium layer.
Patent EA-014867-B1 (EA)
Title: Airborne vehicle
Inventor: GOSLING HARRY GEORGE DENNIS
IPC: B64C39/02
Filed: 2008-04-16
Abstract: An airborne vehicle having a wing-body which defines a wing-body axis and appears substantially annular when viewed along the wing-body axis, the interior of the annulus defining a duct which is open at both ends. A propulsion system is provided comprising one or more pairs of propulsion devices, each pair comprising a first propulsion device mounted to the wing-body and positioned on a first side of a plane including the wing-body axis, and a second propulsion device mounted to the wing-body and positioned on a second side of the plane including the wing-body axis. A direction of thrust of the first propulsion device can be adjusted independently of the direction of thrust of the second propulsion device and/or a magnitude of thrust of the first propulsion device can be adjusted independently of the magnitude of thrust of the second propulsion device. In certain embodiments the wing-body appears swept forward when viewed from a first viewing angle, and swept backward when viewed from a second viewing position at right angles to the first viewing angle.
Patent EA-017971-B1 (EA)
Title: Method for producing castings by means of directed crystallisation from determined area of the melt towards the casting periphery
Inventor: ANISIMOV OLEG VLADIMIROVICH
IPC: B22D27/00
Filed: 2008-10-03
Abstract: The invention relates to foundry engineering. The method for producing castings by means of directed crystallisation of the melt from the determined area towards the casting periphery involves shaping a casting in a crystalliser, the thermodynamic characteristics of which provide the uniform volumetric cooling of a melt to the end temperature of natural crystallization processes. In order to achieve the isotropy of the casting structure such cooling is performed at no more than 0.5 DEG C/s. The casting is formed in an irregular force field which is produced by ultrasonic oscillations focused on a determined area of the melt in such a way that a local high-pressure zone and a crystallisation center are formed therein and a crystallisation front is directed from said zone towards the casting periphery. The irregular force field in the crystalliser is saved until the end temperature of natural crystallisation processes is achieved while the melt is cooled. The melt, prior to be poured in the crystalliser, is overheated by a quantity which, in combination with the thermodynamic characteristics of the crystallizer which ensure the melt cooling at a rate equal to or less than 0.5 DEG C/s, provides the time for liquid phase of the melt enough to end organized directed crystallization of the melt from the determined areal towards the casting periphery. When the end temperature of natural crystallisation processes is achieved, the irregular force field is removed and further cooling of the melt can be performed at any rate.
Patent EA-023345-B1 (EA)
Title: Pesticidal mixtures
Inventor: GEWEHR MARKUS
IPC: A01P21/00
Filed: 2010-12-03
Abstract: The present invention relates to an agrochemical mixture for increasing the health of a plant, comprising as active ingredients: 1) a herbicidal compound (I) selected from the group consisting of: (i) benzoic acids, selected from chloramben, dicamba and 2,3,6-TBA; (ii) pyridine carboxylic acids, selected from clopyralid, fluroxypyr, picloram and triclopyr; (iii) benazolin-ethyl; and 2) a fungicidal compound (II) selected from the group consisting of N-(3',4',5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide (common name: fluxapyroxad), N-[2-(4'-trifluoromethylthio)biphenyl]-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide (common name: bixafen), N-[2-(1,3-dimethylbutyl)phenyl]-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide (common name: penflufen), N-(2-bicyclopropyl-2-yl-phenyl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide (common name: sedaxane), N-[1,2,3,4-tetrahydro-9-(1-methylethyl)-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (common name: isopyrazam), N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide (common name: penthiopyrad), boscalid, fluopyram, flutolanil, furametpyr, mepronil and thifluzamide in synergistically effective amounts, wherein the health of a plant is defined as better crop yields, plant vigor, quality and resistance to abiotic and/or biotic stresses. The present invention further relates to a method for improving the health of a plant, wherein the plant, the locus where the plant is growing or is expected to grow or plant propagation material from which the plant grows is treated with an effective amount of a mixture as defined above. In addition, the invention relates to the use of a mixture as defined above for synergistically increasing the health of a plant.
Patent EA-022217-B1 (EA)
Title: Polypropylene with specific calcium stearate content for special capacitors
Inventor: JACOBS FRANCISCUS
IPC: H01G4/33
Filed: 2011-05-06
Abstract: Capacitor film comprising a biaxially oriented polypropylene (BOPP) and more than 100 to below or equal 400 ppm of an alkali earth fatty acid salt.
Patent EA-022158-B1 (EA)
Title: Modulators of fatty acid amide hydrolase activity
Inventor: KEITH JOHN M
IPC: C07D405/12
Filed: 2011-05-02
Abstract: 4-(2,2-Difluorobenzo[1,3]dioxol-5-ylmethyl)piperazine-1-carboxylic acid (4-chloropyridin-3-yl)amide is described, which is useful as a FAAH modulator. 4-(2,2-Difluorobenzo[1,3]dioxol-5-ylmethyl)piperazine-1-carboxylic acid (4-chloropyridin-3-yl)amide may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and pathological conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). A method of synthesizing 4-(2,2-difluorobenzo[1,3]dioxol-5-ylmethyl)piperazine-1-carboxylic acid (4-chloropyridin-3-yl)amide is also disclosed.
Patent EA-025376-B1 (EA)
Title: Hydrometallurgical method for recovering zinc in a sulphuric medium from zinc sulphide concentrates having a high iron content
Inventor: TAMARGO GARCIA FRANCISO JOSE
IPC: C22B19/20
Filed: 2012-07-16
Abstract: This method is based on the recirculation of a solution containing no, or a low content of, iron, such that the final acidity conditions achieved are suitable for obtaining efficient precipitation of iron in the form of jarosite. In one embodiment, the zinc concentrate is subjected to the following steps: a) roasting of at least part of the zinc concentrate; b) neutral leaching, in which the zinc oxide is dissolved; c) acid leaching, in which the zinc ferrites are leached; d) reduction of the Fecontained in the Fesolution by means of the addition of zinc concentrate and dilution with zinc sulphate solution originating from step (f) in order to reduce the concentration of Fe; e) neutralisation of the acidity of the solution with calcine; f) oxidation of iron and precipitation of jarosite, free of solid contaminants, by means of the injection of oxygen or oxygen-enriched air and the addition of an alkali or a salt of Naor NH.
Patent EA-022622-B1 (EA)
Title: Device and method for dispensing a liquid product that is to be sprayed onto a surface
Inventor: BALLU PATRICK JEAN MARIE
IPC: A01M7/00
Filed: 2011-07-29
Abstract: This device (1) comprises a spray boom (5) which comprises several consecutive ducts (6) with at least one inlet (7) connected to a source (3) of liquid product (2) and outlets that communicate with nozzles (8). This device (1) further comprises several sensors (9) for measuring a quantity that will enable a pressure difference between ducts or a pressure in a respective duct (6) to be determined, several members (11) designed to vary the pressures obtaining in respective ducts (6), and at least one control unit (12) that evaluates the differences in pressure between ducts (6) and controls the members (11) in such a way as to reduce these pressure differences or to even out these pressures. Thus, this device (1) limits the differences in pressure, and therefore in flow rate, of the liquid product between the nozzles (8), particularly between the ends of long spray booms travelling over terrain with significant cross fall.
Patent EA-024896-B1 (EA)
Title: Substrate for a photovoltaic cell
Inventor: CINTORA OCTAVIO
IPC: H01L31/0392
Filed: 2012-03-08
Abstract: The invention relates to a substrate for a photovoltaic cell, including at least one float-glass sheet having at least one electrode on one surface thereof, characterized in that the chemical composition of said glass includes the following components in weight contents that vary within the limits defined herein: 69 to 75% of SiO, 0 to 3% of AlO, 11 to 16.2% of CaO+MgO, 0 to 6.5% of MgO, 9 to 12.4% of NaO, and 0 to 1.5% of KO.